Epilepsy Nerve Pain THC Treatment 
TheAnswerPage
MAY 20, 2022
Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms).
TheAnswerPage
AUGUST 19, 2021
Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TheAnswerPage
JUNE 14, 2021
Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms).”
Cannabis Law Report
AUGUST 21, 2019
Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.
The Joint Blog
JUNE 4, 2021
Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
The Joint Blog
MAY 13, 2019
The focus is mainly on the two out of 100 chemicals known as Tetrahydrocannabinol (THC) and Cannabidiol(CBD). Recreational marijuana comes with a higher level of THC and is meant to provide consumers with the ‘high’ which comes as a side effect to its consumption. So what makes it different from its recreational cousin?
The Cannigma
SEPTEMBER 26, 2021
There are currently five types of cannabis that are made by the company Bedrocan for the OMC, with THC levels ranging from 1% to around 22%, and CBD levels that range from less than 1% to over 9%. The OMC provides medical cannabis exclusively to pharmacies, hospitals, pharmacy-holding GP’s, and veterinarians.
Expert insights. Personalized for you.
52 
Let's personalize your content